OCRF & Ovarian Cancer National Alliance are now one strong, united, inspiring voice!
Ovarian Cancer Research Fund (OCRF) and the Ovarian Cancer National Alliance (OCNA) have led the way in advocacy, research and support for patients and their families for over 22 years. As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Fund Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families. Read the exciting news!


2007 Program Project Development Grant Recipient – Jonathan Berek

Jonathan Berek, M.D., MMSC
Stanford University
Leading the Effort to Develop Vaccines and Immunotherapy for Ovarian Cancer

Project Summary

Dr. Berek is the Principal investigator of the Cooperative Ovarian Cancer Group for Immunotherapy (COGI), a consortium of ovarian cancer researchers from 22 leading academic medical centers in the United States and United Kingdom that was formed in 2004 to focus on the development of vaccines and innovative immunotherapy for ovarian cancer. COGI goals are to coordinate clinical investigators dedicated to conducting innovative trials of vaccines and immunotherapy in ovarian cancer, to translate research from the laboratory bench top to the clinic, to facilitate relationships with industry in treatment development and to raise money to keep the consortium going.


Dr. Berek is Professor and Chair of the Department of Obstetrics and Gynecology at Stanford University School of Medicine, the Chief of Obstetrics and Gynecology at Stanford Hospital & Clinics, as well as Co-Director of the Women’s Cancer Program at the Stanford Cancer Center. Before joining Stanford in December of 2005, Dr. Berek spent more than two decades at UCLA where he was Chair of the College of Applied Anatomy at the David Geffen School of Medicine at UCLA, the Executive Vice Chair of the Department of Obstetrics and Gynecology, Chief of the Division of Gynecologic Oncology and the Gynecology Service, Director of the UCLA Women’s Reproductive Cancer Program, and Chief of Staff of the UCLA Medical Center.

Dr. Berek’s primary areas of interest are in the development of novel therapies and vaccines for cancer, and stem cell investigations on ovarian cancer. He has contributed over 400 publications to the scientific literature. He is the Group Chair and Principal Investigator of the Cooperative Group for Immunotherapy in Ovarian Cancer (COGI).

Dr. Berek received an undergraduate degree in 1970 from Brown University in English and American Literature/Theatre Arts and Dramatic Literature, and an M.M.S. in Biomedical Sciences in 1973 from Brown. After receiving his medical degree from Johns Hopkins University School of Medicine in 1975, he completed an internship, residency, and fellowship at Harvard Medical School, the Brigham & Women’s Hospital. He completed his fellowship in Gynecologic Oncology at the UCLA School of Medicine in 1981.

Publications and Press

“Women Who Keep Ovaries Live Longer,” New York Times, April 29, 2009. (Dr. Berek was an author of the study mentioned in this article.)

“Berek on the Health Risks of Removing Ovaries.” Stanford University News Service, April 29, 2009.

For a full list of Dr. Berek’s publications, click here.